ProductLife Group

[𝗙𝗿𝗲𝗲 𝗪𝗲𝗯𝗶𝗻𝗮𝗿] 𝗘𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗦𝘁𝗲𝗽𝘀 𝘁𝗼 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗮 𝗦𝘁𝗿𝗼𝗻𝗴 𝗟𝗦𝗢 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 📅 Mark your calendars for 𝗔𝗽𝗿𝗶𝗹 𝟭𝟬𝘁𝗵! 🕑 𝟭𝟲:𝟬𝟬 – 𝟭𝟳:𝟬𝟬 𝗖𝗘𝗧 🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/efKa-7Mg As 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀  continue to evolve, establishing a strong 𝗟𝗼𝗰𝗮𝗹 𝗦𝗮𝗳𝗲𝘁𝘆 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 (𝗟𝗦𝗢) 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 is critical to ensuring patient safety, regulatory compliance, and effective risk management at a local level. Join us as we break down the 𝗸𝗲𝘆 𝘀𝘁𝗲𝗽𝘀 𝘁𝗼 𝗱𝗲𝘀𝗶𝗴𝗻𝗶𝗻𝗴 𝗮𝗻𝗱 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗮 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 𝗟𝗦𝗢 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸. ✔ 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂’𝗹𝗹 𝗹𝗲𝗮𝗿𝗻: ·      Regulatory expectations and compliance essentials ·      Best practices for implementing a successful LSO program ·      Industry insights on overcoming global PV challenges 🎤 𝗠𝗲𝗲𝘁 𝗢𝘂𝗿 𝗘𝘅𝗽𝗲𝗿𝘁𝘀:  ·      Lucy Green – QPPV/LSO Director, EU ·      Beth Shaleesh – Head of PV Account Management, NA 💡 Don’t miss this opportunity to strengthen your pharmacovigilance strategy and ensure compliance with evolving global regulations! #Pharmacovigilance #LSOProgram #DrugSafety #RegulatoryCompliance #LifeSciences #HealthcareWebinar #FreeWebinar #PVCompliance #PatientSafety #GlobalRegulations #PharmaIndustry #RiskManagement #MedicalCompliance #LocalSafetyOfficer #PharmacovigilanceExperts

🎉It's a proud moment for ProductLife Group Mauritius! Achieving the 𝗚𝗿𝗲𝗮𝘁 𝗣𝗹𝗮𝗰𝗲 𝗧𝗼 𝗪𝗼𝗿𝗸® 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 is a testament to the team's dedication, strong leadership, and shared vision for the future. With 93% of employees recognizing the clarity in leadership and direction, this milestone speaks volumes about the company culture. Congratulations to the entire team on this well-earned recognition! 👏👏 #GreatPlaceToWork #GPTW #GPTWMauritius #GPTW4All #WorkplaceCulture #ProductLifeGroup

[𝗙𝗿𝗲𝗲 𝗪𝗲𝗯𝗶𝗻𝗮𝗿] 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘆𝗼𝘂𝗿 𝗹𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 ‼️ Grab your chance to join us in this webinar addressing 𝗘𝗨 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟰/𝟭𝟴𝟲𝟬: 𝗜𝗻𝘁𝗲𝗿𝘂𝗽𝘁𝗶𝗼𝗻 & 𝗗𝗶𝘀𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 on the 𝟮𝟬𝘁𝗵 𝗼𝗳 𝗠𝗮𝗿𝗰𝗵, 𝟮𝟬𝟮𝟱, at 𝟭𝟭:𝟯𝟬𝗔𝗠, led by expert consultants, Clémence Luyssaert & Samuel Buet. ✍ 𝗪𝗵𝗮𝘁 𝘆𝗼𝘂’𝗹𝗹 𝗹𝗲𝗮𝗿𝗻: • Strategies to navigate new regulatory challenges; • Best practices for risk management and compliance; • Key considerations to maintain device availability. ➡️ Don't miss out! Register here: https://lnkd.in/eK_bc4Sx

💡 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗸𝗲𝘆 𝗳𝗼𝗿 𝗮 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗲𝗱𝗴𝗲 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲! Patient Access Monitor transforms the management of EMA and AIFA-registered drugs, offering real-time regulatory and Market Access data. 👉 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗶𝘁? An intuitive platform providing quick, secure access to essential drug information, optimizing workflows, and supporting decision-making. 🔮 𝗙𝘂𝘁𝘂𝗿𝗲-𝗥𝗲𝗮𝗱𝘆 𝘄𝗶𝘁𝗵 𝗖𝗹𝗼𝘂𝗱 & 𝗔𝗜 In 2025, we’re upgrading with Cloud and AI for faster, smarter data management. ✨ 𝗪𝗵𝘆 𝗰𝗵𝗼𝗼𝘀𝗲 𝗶𝘁? • Centralized, real-time drug info  • Full support for regulatory and market access  • Continuous innovation with Cloud & AI 📅 𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀 for a demo and see how it can improve your workflow and decision-making. The future is digital, and we’re here to help! #ProductLifeGroup #Innovation #DigitalTransformation #Pharmaceutical #HealthTech #MarketAccess #AI #CloudComputing #Regulatory #Healthcare 

📣 𝗗𝗜𝗔 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟱 𝗸𝗶𝗰𝗸𝘀 𝗼𝗳𝗳 𝗧𝗢𝗠𝗢𝗥𝗥𝗢𝗪 – 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗶𝗻 𝗕𝗮𝘀𝗲𝗹! We’re excited to be at 𝗗𝗜𝗔 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟱 between 𝟭𝟴-𝟮𝟬 𝗠𝗮𝗿𝗰𝗵 in 𝗕𝗮𝘀𝗲𝗹, 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱. This year's conference emphasizes sustainability, innovation, and collaboration—key pillars in advancing healthcare. 📲 𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝗼𝗻 𝗠𝘆 𝗗𝗜𝗔 𝗮𝗽𝗽 𝘁𝗼𝗱𝗮𝘆 to schedule meetings with our team: ·      Albert Ballester Vila-Pagès – Corporate Development Director ·      Melissa Bou Jaoudeh – Innovation & Product Development Officer ·      Maxim Bacher – Strategy and M&A Associate 💡 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝗠𝗲𝗹𝗶𝘀𝘀𝗮 𝗕𝗼𝘂 𝗝𝗮𝗼𝘂𝗱𝗲𝗵’𝘀 𝗲𝗣𝗼𝘀𝘁𝗲𝗿: "Addressing the Complexity of Oligonucleotide Impurities: Analytical Methods and Regulatory Thresholds" she will present from March 18th to 20th. This poster highlights the challenges of impurity detection, classification, and qualification for oligonucleotide therapeutics. By leveraging advanced analytical techniques and evolving regulatory frameworks (EMA, FDA, ICH), Melissa emphasizes the importance of impurity characterization and qualification in ensuring patient safety. Thanks to PLG’s experts, you can better understand the critical role of impurity control in mitigating potential toxicity risks and get support in managing this risk within the regulatory compliance and pharmaceutical safety framework. Looking forward to insightful discussions—see you in Basel! #DIAEurope2025 #LifeSciences #RegulatoryAffairs #ProductDevelopment #RNAtherapeutics #Pharma #Biotech #Networking

✨ 𝗔 𝗡𝗶𝗴𝗵𝘁 𝘁𝗼 𝗥𝗲𝗺𝗲𝗺𝗯𝗲𝗿 𝗮𝘁 𝘁𝗵𝗲 𝗢𝗽é𝗿𝗮 𝗱𝗲 𝗣𝗮𝗿𝗶𝘀! ✨ The 𝟰𝘁𝗵 𝗲𝗱𝗶𝘁𝗶𝗼𝗻 of our exclusive 𝗖-𝗟𝗲𝘃𝗲𝗹 𝗲𝘃𝗲𝗻𝘁, "𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀’ 𝗡𝗲𝘅𝘁 𝗙𝗿𝗼𝗻𝘁𝗶𝗲𝗿" last night was a resounding success! We were honored to welcome 𝟭𝟱𝟳 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗳𝗿𝗼𝗺 𝟭𝟮𝟭 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀, all gathered to exchange ideas, challenge perspectives, and explore 𝗵𝗼𝘄 𝘁𝗼 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗮 𝘀𝘁𝗿𝗲𝘀𝘀𝗲𝗱 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁. ·   𝗔𝗻 𝗨𝗻𝗳𝗼𝗿𝗴𝗲𝘁𝘁𝗮𝗯𝗹𝗲 𝗦𝗲𝘁𝘁𝗶𝗻𝗴 – Guests had the exclusive opportunity to explore the breathtaking Opéra de Paris. The tour ended with big smiles, as attendees were captivated with the beauty and grandeur of this iconic venue. ·   𝗧𝗵𝗼𝘂𝗴𝗵𝘁-𝗣𝗿𝗼𝘃𝗼𝗸𝗶𝗻𝗴 𝗣𝗮𝗻𝗲𝗹 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻 – Diana Schillag (Air Liquide), Etienne TICHIT (Novo Nordisk France), and Frédéric Desdouits (Treefrog Therapeutics) formed an amazing panel, sharing powerful insights on the evolving landscape of Life Sciences. The panel was expertly moderated by Shawn W. Bates (ProductLife Group), who led a compelling conversation on the industry's most pressing challenges and opportunities. ·   𝗨𝗻𝗽𝗮𝗿𝗮𝗹𝗹𝗲𝗹𝗲𝗱 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 – With so many industry leaders in one room, new connections were made, fresh ideas emerged, and collaborative opportunities took shape. 🌟 𝗛𝗼𝗻𝗼𝗿𝗲𝗱 𝘁𝗼 𝗛𝗼𝘀𝘁, 𝗚𝗿𝗮𝘁𝗲𝗳𝘂𝗹 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗚𝗿𝗼𝘄𝘁𝗵 – Each year, PLG is privileged to bring this incredible community together, and we are truly grateful for the increasing success and enthusiasm from our clients. Your engagement and positive energy continue to make this event more impactful and rewarding every year! A huge thank you to all who joined us! 𝗧𝗵𝗶𝘀 𝗶𝘀 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴—𝘀𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗺𝗲𝗺𝗼𝗿𝗮𝗯𝗹𝗲 𝗺𝗼𝗺𝗲𝗻𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗻𝗶𝗴𝗵𝘁. 📸 𝗛𝗲𝗿𝗲’𝘀 𝗮 𝗳𝗶𝗿𝘀𝘁 𝗴𝗹𝗶𝗺𝗽𝘀𝗲! #LifeSciences #Innovation #Leadership #Networking #Consulting #Digital #NextFrontier #OperaDeParis

💊 𝗘𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝗮𝗹 𝗔𝘂𝘁𝗵𝗼𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗖𝘆𝗽𝗿𝘂𝘀  Ensuring the availability of medicinal products is a top priority in Cyprus. As an EU Member State, the Department of Pharmaceutical Services oversees various licensing procedures, including special marketing authorizations under Article 126a of Directive 2001/83/EC. In our latest article, we explore: • The role of the Common European Submission Platform (CESP) in streamlining submissions. • Licensing procedures such as National, Decentralized, and Centralized Approvals. • The Special Marketing Authorization process allows access to essential medicines for public health reasons. • Key eligibility criteria, regulatory requirements, and renewal procedures for special authorizations. 📖 Read the full article to learn more about how Cyprus maintains a robust regulatory framework for medicinal product approvals: https://lnkd.in/e6rTQbCQ #Pharmaceuticals #Regulations #Cyprus #EUCompliance #Healthcare #ProductLifeGroup

💊 [🆆🅴🅱🅸🅽🅰🆁] 𝐋𝐞𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐥𝐬, 𝐩𝐚𝐫𝐭𝐞𝐧𝐚𝐢𝐫𝐞𝐬 𝐜𝐥𝐞́𝐬 𝐝𝐮 𝐛𝐨𝐧 𝐮𝐬𝐚𝐠𝐞 𝐝𝐞𝐬 𝐩𝐫𝐨𝐝𝐮𝐢𝐭𝐬 𝐝𝐞 𝐬𝐚𝐧𝐭𝐞́ ? Are pharmaceutical industries key partners in the proper use of healthcare products? 🎙 With Maurice-Pierre Planel, former President of the CEPS (economic committee for health products) and Eric Baseilhac, President of the ABUM (association for the proper use of medicines), on tuesday 18 March from 11.00am to 12.00pm, by videoconference   The proper use of medicines is a major issue, with a decisive impact on patient health, public finances, and the organization of healthcare. It must be everyone's business, not least that of the healthcare industry. How can they play a key role in developing innovative solutions to support healthcare professionals and encourage patient compliance? To what extent could actions to promote proper use be more widely recognised or promoted by the public authorities?   This webinar will provide an opportunity to explore the challenges that the correct use of products represents for our healthcare system, the levers for action available to manufacturers, the best practices observed in the service of more efficient and sustainable care pathways, and the prospects for enhancing the value of the actions implemented. 📌 Read more about it and register on: https://lnkd.in/e9pVB8MF #webinar #healthcare #medicines #industry

📣 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗮𝘁 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝗶𝗻 𝗠𝗶𝗹𝗮𝗻! ProductLife Group’s Geary H. (Business Development Director, Product Development Solutions) and Hélène Masset (Head of Business Development Safety & Regulatory Europe) will be attending EBD Group 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 2025 in 𝗠𝗶𝗹𝗮𝗻, 𝗜𝘁𝗮𝗹𝘆, 𝗳𝗿𝗼𝗺 𝗠𝗮𝗿𝗰𝗵 𝟭𝟳-𝟭𝟵. 📲 Reach out to Geary and Helene on 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝗢𝗻𝗲 to book a meeting to discussion your discuss your licensing projects, development and regulatory strategy needs. Looking forward to insightful discussions and networking—see you in Milan! #BIOEuropeSpring #ProductDevelopment #LifeSciences #Biotech #Networking

💻 [𝗙𝗿𝗲𝗲 𝗪𝗲𝗯𝗶𝗻𝗮𝗿] Regulatory updates for Food supplements in EU 𝗗𝗮𝘁𝗲: March 20th, 2024 𝗧𝗶𝗺𝗲: 3:00 PM – 4:00 PM (CET) 🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗛𝗲𝗿𝗲: https://bit.ly/4ib3xr4 Join us for our FREE Webinar on Regulatory updates for Food Supplements in Europe. This webinar will provide valuable insights into: ·      Review of new rules and obligations applicable since 2024 ·      News to follow for the year 2025 ·      Opportunities and points of attention Hosted by a ProductLife Group, this session will feature Merve Çiftci Kantar and Emilie Chauvigné as expert speakers. 💡 Whether you're a regulatory expert in Nutrition, this webinar will equip you with the knowledge to stay compliant and proactive in a rapidly changing regulatory landscape. 📌 Don’t miss this opportunity to strengthen your expertise and ensure compliance success! More information : rni.conseil@productlife-group.com #FoodSupplement #RNINews